It was a pleasure to meet with Dr Wayne Anderson (UNC School of Medicine, Chapel Hill, NC, US) to discuss his recent study evaluating the safety and tolerability of BIO‑11006 in patients with acute respiratory distress syndrome.
‘A Phase II, Placebo‑Controlled, Multicenter Pilot Study to Evaluate the Safety and Efficacy of BIO‑11006 Inhalation Solution in Patients with Acute Respiratory Distress Syndrome.‘ (ABSTRACT NUMBER: A2668) was presented at ATS 2021 International Conference, 14-19 May, 2021.
Questions
- What were the aims and design of your study investigating BIO‑11006 in patients with acute respiratory distress syndrome? (0:17)
- What were the efficacy and safety findings of the study? (3:06)
- On the basis of these findings, what will be the next step in the clinical development of BIO-11006? (8:17)
Disclosures: Wayne Anderson has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Victoria Jones.
Filmed as a highlight of ATS 2021 (Virtual).
